ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Adaptive Biotechnologies Corp

Filed

February 11, 2020

Accession Number

0001387131-20-001273

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →